Browse our anti-TNFSF15 (TNFSF15) Antibodies

Full name:
anti-Tumor Necrosis Factor (Ligand) Superfamily, Member 15 Antibodies (TNFSF15)
On www.antibodies-online.com are 171 Tumor Necrosis Factor (Ligand) Superfamily, Member 15 (TNFSF15) Antibodies from 23 different suppliers available. Additionally we are shipping TNFSF15 Proteins (37) and TNFSF15 Kits (13) and many more products for this protein. A total of 232 TNFSF15 products are currently listed.
Synonyms:
Tl1, Tl1a, TTPAL, Vegi, VEGI192A
list all antibodies Gene Name GeneID UniProt
TNFSF15 9966 O95150
TNFSF15 326623 Q5UBV8
TNFSF15 252878 Q8K3Y7

Show all species

Show all synonyms

Most Popular Reactivities for anti-TNFSF15 (TNFSF15) Antibodies

Select your species and application

anti-Human TNFSF15 Antibodies:

anti-Mouse (Murine) TNFSF15 Antibodies:

anti-Rat (Rattus) TNFSF15 Antibodies:

All available anti-TNFSF15 Antibodies

Go to our pre-filtered search.

Top referenced anti-TNFSF15 Antibodies

  1. Human Polyclonal TNFSF15 Primary Antibody for EIA, IF - ABIN955278 : Amre, Mack, Morgan, Israel, Deslandres, Seidman, Lambrette, Costea, Krupoves, Fegury, Dong, Xhu, Grimard, Levy: Association between genome-wide association studies reported SNPs and pediatric-onset Crohn's disease in Canadian children. in Human genetics 2010 (PubMed)
    Show all 5 references for 955278

  2. Human Polyclonal TNFSF15 Primary Antibody for FACS, IF - ABIN655822 : Heidemann, Chavez, Landers, Kucharzik, Prehn, Targan: TL1A selectively enhances IL-12/IL-18-induced NK cell cytotoxicity against NK-resistant tumor targets. in Journal of clinical immunology 2010 (PubMed)
    Show all 5 references for 655822

  3. Human Polyclonal TNFSF15 Primary Antibody for IF (p), IHC (p) - ABIN709556 : ?lebioda, Bojarska-Junak, Stanis?awowski, Cyman, Wierzbicki, Roli?ski, Celi?ski, Kmie?: TL1A as a potential local inducer of IL17A Expression in colon mucosa of inflammatory bowel disease patients. in Scandinavian journal of immunology 2015 (PubMed)

More Antibodies against TNFSF15 Interaction Partners

Human Tumor Necrosis Factor (Ligand) Superfamily, Member 15 (TNFSF15) interaction partners

  1. Data suggest that human regulatory T-lymphocytes express DR3 (show TNFRSF25 Antibodies) and demonstrate DR3 (show TNFRSF25 Antibodies)/TL1A-mediated activation of signaling via MAP kinases and NFkappaB (show NFKB1 Antibodies). (DR3 (show TNFRSF25 Antibodies) = death receptor 3 (show TNFRSF25 Antibodies); TL1A/TNFSF15 = tumor necrosis factor (show TNF Antibodies) [ligand] superfamily, member 15)

  2. These results raise the possibility for involvement of TL1A/DR3/DR3 (show TNFRSF25 Antibodies)-mediated mechanisms in epithelial-mesenchymal interactions and the development of inflammation-induced intestinal fibrosis in Crohn's disease.

  3. rs1250569 (ZMIZ1) and rs10114470 (TL1A) are two novel loci that indicate susceptibility to Inflammatory Bowel Disease in Han-Chinese patients.

  4. results support an idea that the genetic susceptibility of TNFSF15 to CD may be confounded, in part, by the increase of Prevotella

  5. (188)Re-NGR (show RTN4R Antibodies)-VEGI has the potential as a theranostic agent.

  6. miRNA-31 can directly bind to the 3-UTR (show UTS2R Antibodies) of TNFSF15, thereafter negatively regulating its expression in Caco2 cells.

  7. Patients with mild traumatic brain injury (TBI) exhibited higher VEGI levels than those with moderate and severe TBI.

  8. Biologics beyond TNF-alpha (show TNF Antibodies) inhibitors and the effect of targeting the homologues TL1A-DR3 (show TNFRSF25 Antibodies) pathway in chronic inflammatory disorders.

  9. Rs3810936 of TNFSF15 were related to the risk of ankylosing spondylitis

  10. Higher TL1A levels were associated with early stage chronic lymphocytic leukemia.

Mouse (Murine) Tumor Necrosis Factor (Ligand) Superfamily, Member 15 (TNFSF15) interaction partners

  1. this study shows that TL1A-/- mice are more susceptible to dextran sodium sulfate colitis

  2. These data demonstrated a direct role for TL1A-DR3 (show TNFRSF25 Antibodies) signaling in tissue fibrosis and that modulation of TL1A-DR3 (show TNFRSF25 Antibodies) signaling could inhibit gut (show GUSB Antibodies) fibrosis.

  3. these data identify TL1A-DR3 (show TNFRSF25 Antibodies) interactions as a novel pathway that promotes Th9 differentiation and pathogenicity. TL1A may be a potential therapeutic target in diseases dependent on IL-9 (show IL9 Antibodies).

  4. TL1A induces NF-kappaB (show NFKB1 Antibodies) activation in EC in renal and cardiac tissue from wild type but not DR3 (show TNFRSF25 Antibodies) knock-out mice.

  5. TL1A deficiency impacts on the gut (show GUSB Antibodies) microbial composition and the mucosal immune system, especially the intraepithelial TCRgammadelta(+) T-cell subset, and that TL1A is involved in the establishment of adipose tissue.

  6. Our data demonstrate a key role for TL1A in promoting ILC2s at mucosal barriers.

  7. TNFSF15 inhibits vasculogenesis by regulating relative levels of membrane-bound and soluble isoforms of VEGF receptor (show FLT1 Antibodies) 1.

  8. Both in supernatant and as purified fusion protein, TL1A-Ig binds to TNFRSF25 (show TNFRSF25 Antibodies) transfected--but not untransfected--P815 tumor cells as determined by flow cytometry.

  9. These results establish a novel link between tumor necrosis factor (TNF (show TNF Antibodies))-family cytokine TL1A (TNFSF15) and interleukin 13 (IL-13 (show IL13 Antibodies)) responses that results in small intestinal inflammation.

  10. role of TL1A in mucosal T cells and antigen presenting cells function and showed that up-regulation of TL1A expression can promote mucosal inflammation and gut (show GUSB Antibodies) fibrosis.

TNFSF15 Antigen Profile

Antigen Summary

The protein encoded by this gene is a cytokine that belongs to the tumor necrosis factor (TNF) ligand family. This protein is abundantly expressed in endothelial cells, but is not expressed in either B or T cells. The expression of this protein is inducible by TNF and IL-1 alpha. This cytokine is a ligand for receptor TNFRSF25 and decoy receptor TNFRSF21/DR6. It can activate NF-kappaB and MAP kinases, and acts as an autocrine factor to induce apoptosis in endothelial cells. This cytokine is also found to inhibit endothelial cell proliferation, and thus may function as an angiogenesis inhibitor. Two transcript variants encoding different isoforms have been found for this gene.

Alternative names and synonyms associated with TNFSF15

  • tumor necrosis factor (ligand) superfamily, member 15 (TNFSF15) antibody
  • tumor necrosis factor (ligand) superfamily, member 15 (Tnfsf15) antibody
  • Tl1 antibody
  • Tl1a antibody
  • TTPAL antibody
  • Vegi antibody
  • VEGI192A antibody

Protein level used designations for TNFSF15

tumor necrosis factor ligand superfamily member 15 , vascular endothelial growth inhibitor , tocopherol (alpha) transfer protein-like , TNF ligand-related molecule 1 , TNF superfamily ligand TL1A , vascular endothelial cell growth inhibitor , vascular endothelial growth inhibitor-192A , bM20K13.3 (tumor necrosis factor (ligand) superfamily, member 15)

GENE ID SPECIES
417247 Gallus gallus
473468 Pan troglodytes
9966 Homo sapiens
326623 Mus musculus
252878 Rattus norvegicus
481688 Canis lupus familiaris
100624969 Sus scrofa
514239 Bos taurus
100725797 Cavia porcellus
Selected quality suppliers for anti-TNFSF15 (TNFSF15) Antibodies
Did you look for something else?